Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit
Veeva Systems (NYSE: VEEV) has announced the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept. 9-10. This event, one of the largest in life sciences, will bring together over 2,000 industry professionals to discuss how connected systems across clinical, regulatory, safety, and quality can advance drug development.
Keynote speakers from leading companies like AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, and Roche will share insights on various topics. These include pharmacovigilance transformation, clinical process optimization, scalable development foundations, quality control modernization, and AI-powered translation for faster submissions.
Veeva CEO Peter Gassner will headline the opening keynote, focusing on how connected data and systems can streamline drug development and accelerate product time to market. The summit will feature over 100 sessions, providing ample networking and learning opportunities for attendees.
Veeva Systems (NYSE: VEEV) ha annunciato il prossimo Veeva R&D e Quality Summit 2024 a Boston, previsto per il 9-10 settembre. Questo evento, uno dei più importanti nel settore delle scienze della vita, riunirà oltre 2.000 professionisti del settore per discutere di come sistemi connessi tra clinico, regolatorio, sicurezza e qualità possono avanzare nello sviluppo dei farmaci.
Relatori di punta provenienti da aziende leader come AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna e Roche condivideranno approfondimenti su vari argomenti. Questi comprendono la trasformazione della farmacovigilanza, l'ottimizzazione dei processi clinici, le fondamenta per uno sviluppo scalabile, la modernizzazione del controllo qualità e la traduzione potenziata dall'IA per accelerare le presentazioni.
Il CEO di Veeva, Peter Gassner, sarà il principale relatore nell'apertura, concentrandosi su come dati e sistemi connessi possano semplificare lo sviluppo dei farmaci e accelerare il tempo di immissione sul mercato dei prodotti. Il summit presenterà oltre 100 sessioni, offrendo ampie opportunità di networking e apprendimento per i partecipanti.
Veeva Systems (NYSE: VEEV) ha anunciado el próximo Veeva R&D y Quality Summit 2024 en Boston, que se celebrará el 9 y 10 de septiembre. Este evento, uno de los más grandes en ciencias de la vida, reunirá a más de 2,000 profesionales de la industria para discutir cómo los sistemas conectados a lo largo de clínico, regulatorio, seguridad y calidad pueden avanzar en el desarrollo de medicamentos.
Oradores principales de empresas líderes como AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna y Roche compartirán sus perspectivas sobre diversos temas. Estos incluyen la transformación de la farmacovigilancia, la optimización de procesos clínicos, las bases de desarrollo escalable, la modernización del control de calidad y la traducción impulsada por IA para acelerar presentaciones.
El CEO de Veeva, Peter Gassner, será el orador principal en la apertura, centrándose en cómo los datos y sistemas conectados pueden agilizar el desarrollo de medicamentos y acelerar el tiempo de comercialización del producto. El summit contará con más de 100 sesiones, proporcionando amplias oportunidades de networking y aprendizaje para los asistentes.
Veeva Systems (NYSE: VEEV)는 오는 9월 9일부터 10일까지 보스턴에서 개최될 2024 Veeva R&D 및 품질 정상 회담을 발표했습니다. 생명 과학 분야에서 가장 큰 행사 중 하나인 이 회의는 2,000명 이상의 업계 전문가들을 모아 임상, 규제, 안전, 품질 전반에 걸친 연결된 시스템이 어떻게 약물 개발을 발전시킬 수 있는지를 논의할 것입니다.
AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, Roche와 같은 선도 기업의 기조 연설자들이 다양한 주제에 대한 통찰력을 공유할 예정입니다. 여기에는 약물 안전 감시의 변환, 임상 프로세스 최적화, 확장 가능한 개발 기초, 품질 관리 현대화 및 빠른 제출을 위한 AI 기반 번역이 포함됩니다.
Veeva의 CEO인 Peter Gassner가 기조 연설을 열어 연결된 데이터와 시스템이 어떻게 약물 개발을 간소화하고 제품의 시장 출시 시간을 단축할 수 있는지에 대해 집중할 것입니다. 이 정상 회담에서는 100개 이상의 세션이 진행되어 참석자들에게 충분한 네트워킹 및 학습 기회를 제공합니다.
Veeva Systems (NYSE: VEEV) a annoncé le prochain Veeva R&D et Quality Summit 2024 à Boston, qui se tiendra les 9 et 10 septembre. Cet événement, l'un des plus importants dans le domaine des sciences de la vie, réunira plus de 2 000 professionnels de l'industrie pour discuter de la manière dont des systèmes connectés à travers le clinico, le réglementaire, la sécurité et la qualité peuvent faire progresser le développement des médicaments.
Des intervenants de premier plan issus d'entreprises telles que AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna et Roche partageront des perspectives sur divers sujets. Ceux-ci incluent la transformation de la pharmacovigilance, l'optimisation des processus cliniques, des fondations de développement évolutives, la modernisation du contrôle qualité et la traduction alimentée par l'IA pour des soumissions plus rapides.
Le PDG de Veeva, Peter Gassner, sera le principal intervenant lors de la keynote d'ouverture, se concentrant sur la manière dont les données et systèmes connectés peuvent rationaliser le développement des médicaments et accélérer le temps de mise sur le marché des produits. Le sommet comprendra plus de 100 sessions, offrant de nombreuses opportunités de réseautage et d'apprentissage pour les participants.
Veeva Systems (NYSE: VEEV) hat den bevorstehenden Veeva R&D und Quality Summit 2024 in Boston am 9.-10. September angekündigt. Diese Veranstaltung, eine der größten im Bereich der Lebenswissenschaften, wird über 2.000 Fachleute der Branche zusammenbringen, um zu besprechen, wie verbundene Systeme in klinischen, regulatorischen, sicherheits- und qualitätsrelevanten Bereichen die Medikamentenentwicklung vorantreiben können.
Keynote-Redner von führenden Unternehmen wie AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna und Roche werden Einblicke zu verschiedenen Themen geben. Dazu gehören die Transformation der Pharmakovigilanz, die Optimierung klinischer Prozesse, skalierbare Entwicklungsgrundlagen, die Modernisierung der Qualitätskontrolle und KI-gestützte Übersetzungen für schnellere Einreichungen.
Veeva-CEO Peter Gassner wird die Eröffnungs-Keynote halten und sich darauf konzentrieren, wie vernetzte Daten und Systeme die Medikamentenentwicklung rationalisieren und die Markteinführungszeit von Produkten verkürzen können. Der Gipfel wird über 100 Sitzungen umfassen und den Teilnehmern reichlich Networking- und Lernmöglichkeiten bieten.
- None.
- None.
AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development
Veeva R&D and Quality Summit is one of the largest life sciences events, drawing more than 2,000 executives to network and learn across more than 100 sessions. Veeva CEO Peter Gassner headlines the opening keynote, sharing innovations and examples of how connected data and systems can significantly streamline drug development and accelerate product time to market. Additional featured keynotes and sessions include:
- AbbVie and Merck discuss the impact of pharmacovigilance transformation on operational visibility and end-to-end efficiency.
- Astellas explains its holistic approach to driving end-to-end clinical processes for increased speed and transparency.
- Eikon Therapeutics highlights the benefits of establishing a foundation for scalable and efficient development from clinical trial to product launch.
- Neurogene and Verve Therapeutics discuss modernizing quality control with simplified processes and digital-first quality execution.
- Sanofi showcases leveraging AI-powered translation for faster submission timelines.
- UCB shares its enterprise eCOA journey to accelerate delivery and standardize patient data capture.
"Veeva is committed to customer success, delivering integrated software, data, and services that can advance innovation for patients in need," said Jim Reilly, vice president of Veeva Development Cloud strategy. "Veeva R&D and Quality Summit brings the industry together to share learnings, fresh ideas, and new strategies to improve collaboration and accelerate the delivery of novel products."
The event is open exclusively to life sciences professionals. Register and stay up to date on the agenda at veeva.com/Summit.
Additional Information
Register for Veeva R&D and Quality Summit: veeva.com/Summit/register
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/life-sciences-community-advances-toward-next-phase-of-innovation-at-veeva-rd-and-quality-summit-302220776.html
SOURCE Veeva Systems
FAQ
When and where is the 2024 Veeva R&D and Quality Summit taking place?
Which companies are keynoting at the Veeva R&D and Quality Summit 2024?
What topics will be discussed at the Veeva R&D and Quality Summit 2024?
How many attendees are expected at the Veeva R&D and Quality Summit 2024?
How can life sciences professionals register for the Veeva R&D and Quality Summit 2024?
